PMID: 8590787Oct 1, 1995Paper

Interaction of glucagon-like peptide-I (GLP-I) and galanin in insulin (beta TC-1)- and somatostatin (RIN T3)-secreting cells and evidence that both peptides have no receptors on glucagon (INR1G9)-secreting cells

Acta Diabetologica
H C FehmannB Göke

Abstract

The interaction of glucagon-like peptide-I (GLP-I) and galanin in clonal endocrine pancreatic cells was characterized. By Northern blot analysis the presence of GLP-I receptor mRNA was shown in B (beta TC-1 cells) and D (RIN 1048-38) cells but not in A (INR1 G9) cells, thus confirming functional data demonstrating the absence of active GLP-I receptors on glucagon-producing cells. Galanin receptors were detected on B and D cells but not on A cells. In B and D cells galanin inhibited the GLP-I stimulated adenylate cyclase activity. Treatment of insulin- and somatostatin-producing cells with GLP-I increased intracellular cAMP levels, and this was dampened by galanin, GLP-I stimulated the activity of protein kinase A in B and D cells, which was also inhibited by galanin. Galanin alone did not influence B- and D-cell function. These data show that in the endocrine pancreas B and D cells but not A cells express GLP-I and galanin receptors. The interaction of GLP-I and galanin might act in the endocrine pancreas as a physiological inhibitor of the potent incretin hormone GLP-I. Therefore, we suggest galanin is a 'decretin'.

References

Apr 1, 1990·The Journal of Clinical Investigation·G C Weir, S Bonner-Weir
Mar 1, 1990·The American Journal of Physiology·S V Brooks, J A Faulkner
Aug 1, 1989·The American Journal of Physiology·E J GutmannD Brown
Mar 1, 1988·The Journal of Endocrinology·R Göke, J M Conlon
Feb 1, 1986·Clinics in Endocrinology and Metabolism·E SamolsG C Weir
May 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·D J DruckerJ F Habener
Aug 1, 1986·The American Journal of Physiology·P A In't VeldW Gepts
Dec 1, 1984·The Journal of Clinical Investigation·H MaruyamaR H Unger
May 1, 1993·Cellular Signalling·A M McDermott, G W Sharp
Jan 1, 1994·Experimental and Clinical Endocrinology·B Lankat-ButtgereitB Göke
Jan 1, 1994·Lancet·S A Amiel
Jan 1, 1993·Research in Experimental Medicine. Zeitschrift Für Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie·R GökeB Göke

❮ Previous
Next ❯

Citations

Mar 20, 2014·European Journal of Nuclear Medicine and Molecular Imaging·Lovisa NalinMarianne Jensen-Waern
Dec 1, 1996·The American Journal of Physiology·G W Sharp
Apr 3, 1999·Neuropeptides·E Karelson, U Langel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.